Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970759 · ClinicalTrials.gov registry record
Meta-analysis of Stannous Fluoride and the Effects on Gingival Health
A clinical trial, sponsored by Procter and Gamble.
- Completed
- Registry status
- 2,890
- Enrollment target
NCT03970759 is a clinical trial that has completed, run by Procter and Gamble. The registered enrollment target is 2,890 participants.
The verdict
NCT03970759 has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- 2,890 participants
- Enrollment target
Study Summary
The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on gingivitis relative to a positive or negative control dentifrice.
Interventions
- DRUG Stannous Fluoride Dentifrice
- DRUG Positive control dentifrice
- DRUG Negative control dentifrice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,890 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2018-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03970759
The ClinicalTrials.gov registry entry for NCT03970759 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,890 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Stannous Fluoride Dentifrice is the first listed.
NCT03970759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03970759 about?
NCT03970759 is a clinical study titled "Meta-analysis of Stannous Fluoride and the Effects on Gingival Health". The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on gingivitis relative to a positive or negative control dentifrice.
What is the current status of trial NCT03970759?
This trial is currently completed. The enrollment target is 2,890 participants. The study started on 2018-01-08. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT03970759?
The interventions under investigation include: Stannous Fluoride Dentifrice (DRUG), Positive control dentifrice (DRUG), Negative control dentifrice (DRUG).
Who is sponsoring clinical trial NCT03970759?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.